Literature DB >> 7624027

Allelic variation of apolipoprotein E in Japanese sporadic Creutzfeldt-Jakob disease patients.

Y Nakagawa1, T Kitamoto, H Furukawa, K Ogomori, J Tateishi.   

Abstract

We analyzed apolipoprotein E (apo E) genotypes in 53 Japanese sporadic Creutzfeldt-Jakob disease (CJD) patients and 100 normal controls using the polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) methods. The apo E allelic frequencies in Japanese sporadic CJD patients and our control population were as follows: epsilon 2, 6.6% versus 7.5%; epsilon 3, 82.1% versus 81.5%; epsilon 4, 11.3% versus 11.0%. The mean ages at onset in Japanese sporadic CJD patients were as follows: epsilon 3/epsilon 3, 63.8 years; epsilon 3/epsilon 4, 66.3 years; epsilon 2/epsilon 3, 68.6 years. These results indicate that there is no association between apo E genotype and sporadic CJD in Japan.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7624027     DOI: 10.1016/0304-3940(95)11366-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study.

Authors:  S Danet; T Brousseau; F Richard; P Amouyel; C Berr
Journal:  J Epidemiol Community Health       Date:  1999-07       Impact factor: 3.710

2.  ApoE distribution and family history in genetic prion diseases in Germany.

Authors:  Anna Krasnianski; Nicolas von Ahsen; Uta Heinemann; Bettina Meissner; Hans A Kretzschmar; Victor W Armstrong; Inga Zerr
Journal:  J Mol Neurosci       Date:  2007-09-11       Impact factor: 3.444

3.  Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.

Authors:  Inês Esteves Baldeiras; Maria Helena Ribeiro; Paula Pacheco; Alvaro Machado; Isabel Santana; Luís Cunha; Catarina Resende Oliveira
Journal:  J Neurol       Date:  2009-05-06       Impact factor: 4.849

Review 4.  Genetic studies in human prion diseases.

Authors:  Byung-Hoon Jeong; Yong-Sun Kim
Journal:  J Korean Med Sci       Date:  2014-04-25       Impact factor: 2.153

5.  The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins.

Authors:  Marcello Rossi; Hideaki Kai; Simone Baiardi; Anna Bartoletti-Stella; Benedetta Carlà; Corrado Zenesini; Sabina Capellari; Tetsuyuki Kitamoto; Piero Parchi
Journal:  Acta Neuropathol Commun       Date:  2019-04-08       Impact factor: 7.801

6.  Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series.

Authors:  T E F Webb; M Poulter; J Beck; J Uphill; G Adamson; T Campbell; J Linehan; C Powell; S Brandner; S Pal; D Siddique; J D Wadsworth; S Joiner; K Alner; C Petersen; S Hampson; C Rhymes; C Treacy; E Storey; M D Geschwind; A H Nemeth; S Wroe; J Collinge; S Mead
Journal:  Brain       Date:  2008-08-30       Impact factor: 13.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.